AIFarm (AIFM) Financial Statements

4 Followers

AIFarm Financial Overview

AIFarm's market cap is currently $2.08K. The company's EPS TTM is $-0.98; its P/E ratio is >-0.01; AIFarm is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 19	Dec 18	Dec 17
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ -10.48K
Operating Income	$ -487.00K	$ -85.30K	$ -608.01K
EBITDA	$ -59.95K	$ -110.58K	$ 81.66K
Net Income	$ -547.00K	$ -109.80K	$ 54.14K
Balance Sheet
Cash & Short-Term Investments	$ 88.27K	$ 97.12K	$ 583.95K
Total Assets	$ 88.27K	$ 97.12K	$ 583.95K
Total Debt	-	$ 0.00	$ 0.00
Net Debt	$ -88.22K	$ -97.12K	$ -583.95K
Total Liabilities	$ 3.48M	$ 3.59M	$ 5.71M
Stockholders' Equity	$ -1.85M	$ -1.95M	$ -3.58M
Cash Flow
Free Cash Flow	$ -590.90K	$ -1.41M	$ -615.27K
Operating Cash Flow	$ -590.90K	$ -1.41M	$ -615.27K
Investing Cash Flow	$ 0.00	$ 0.00	$ 1.28M
Financing Cash Flow	$ 585.79K	$ 704.00K	$ -204.34K

Currency in USD

AIFarm Earnings and Revenue History

Income Statement >

AIFarm Debt to Assets

Balance Sheet >

AIFarm Cash Flow

Cash Flow >

AIFarm Forecast EPS vs Actual EPS

Earnings >